RO87311B - Medicament cu actiune metabolica complexa si procedeu de obtinere a acestuia - Google Patents
Medicament cu actiune metabolica complexa si procedeu de obtinere a acestuiaInfo
- Publication number
- RO87311B RO87311B RO112255A RO11225583A RO87311B RO 87311 B RO87311 B RO 87311B RO 112255 A RO112255 A RO 112255A RO 11225583 A RO11225583 A RO 11225583A RO 87311 B RO87311 B RO 87311B
- Authority
- RO
- Romania
- Prior art keywords
- medicament
- metabolic action
- complex metabolic
- preparing
- same
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 4
- 230000002503 metabolic effect Effects 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 abstract 1
- UAOKXEHOENRFMP-ZJIFWQFVSA-N [(2r,3r,4s,5r)-2,3,4,5-tetraacetyloxy-6-oxohexyl] acetate Chemical compound CC(=O)OC[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)C=O UAOKXEHOENRFMP-ZJIFWQFVSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 150000002214 flavonoid derivatives Chemical class 0.000 abstract 1
- 229960003035 magnesium gluconate Drugs 0.000 abstract 1
- 235000015778 magnesium gluconate Nutrition 0.000 abstract 1
- 239000001755 magnesium gluconate Substances 0.000 abstract 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 230000003285 pharmacodynamic effect Effects 0.000 abstract 1
- 235000008160 pyridoxine Nutrition 0.000 abstract 1
- 239000011677 pyridoxine Substances 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- 235000019157 thiamine Nutrition 0.000 abstract 1
- 239000011721 thiamine Substances 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Inventia se refera la un medicament cu actiune metabolica complexa si la un procedeu de obtinere a acestuia. Medicamentul, conform inventiei, foloseste drept substanta activa pentaacetilglucoza în care suportul glucidic reprezinta un metabolit normal al organismului. Experimentarile clinice au dovedit efecte de stimulare asupra sistemului nervos central al proprietati farmaco dinamice în tratamentul etilismului cronic si al obezitatii. Actiunea metabolica complexa a medicamentului se potenteaza prin asocierea cu gluconat de magneziu, ATP.4Na, piridoxina, tiamina sau derivati flavonoidici.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RO112255A RO87311B (ro) | 1983-10-04 | 1983-10-04 | Medicament cu actiune metabolica complexa si procedeu de obtinere a acestuia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RO112255A RO87311B (ro) | 1983-10-04 | 1983-10-04 | Medicament cu actiune metabolica complexa si procedeu de obtinere a acestuia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RO87311A RO87311A (ro) | 1985-11-20 |
| RO87311B true RO87311B (ro) | 1985-12-01 |
Family
ID=20113715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RO112255A RO87311B (ro) | 1983-10-04 | 1983-10-04 | Medicament cu actiune metabolica complexa si procedeu de obtinere a acestuia |
Country Status (1)
| Country | Link |
|---|---|
| RO (1) | RO87311B (ro) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3645580B2 (ja) * | 1993-10-22 | 2005-05-11 | 株式会社フジモト・ブラザーズ | グルコースエステル誘導体を含有する脳代謝改善剤 |
| CA3102404A1 (en) * | 2018-06-05 | 2019-12-12 | Flagship Pioneering Innovations V, Inc. | Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease |
-
1983
- 1983-10-04 RO RO112255A patent/RO87311B/ro unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RO87311A (ro) | 1985-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kao et al. | Actions of saxitoxin on peripheral neuromuscular systems | |
| Habermann | Inhibition by tetanus and botulinum A toxin of the release of [3H] noradrenaline and [3H] GABA from rat brain homogenate | |
| Luebs et al. | Effect of nitroglycerin, intensain, isoptin and papaverine on coronary blood flow in man: Measured by the coincidence counting technic and rubidium84 | |
| BE901915A (fr) | Procede pour le traitement ou la prevention des maladies provoques par l'acether du facteur d'activation des plaquettes. | |
| YU48323B (sh) | Postupak za dobijanje askorbinske kiseline | |
| EP0727212A3 (en) | Substituted phenylpyrimidine derivatives, for the treatment or prevention of CNS diseases | |
| ES2033871T3 (es) | Un procedimiento para producir una preparacion de insulina para administracion parenteral. | |
| NO177376C (no) | Fremgangsmåte for fremstilling av en farmasöytisk doseringsform basert på en tampongtrykkmetode | |
| UA45942A (uk) | 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція | |
| Sharma | Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in juvenile-onset and maturity-onset diabetes mellitus. | |
| KR860002270A (ko) | 니트렌디핀을 함유하는 고상 약제 및 그의 제조방법 | |
| PT88691A (pt) | Process for the preparation of sucralose compositions | |
| RO87311B (ro) | Medicament cu actiune metabolica complexa si procedeu de obtinere a acestuia | |
| LV5765A4 (lv) | (S)-(-)-1-propil-2',6'-pipekoloksilidida hidrohlorida monohidrats ta iegusanas metode un to satuross farmaceitisks preparats | |
| GR3003388T3 (en) | Imidazolylguanidine derivatives, process for their preparation and medicines containing them | |
| FR2405656A1 (fr) | Nouvelle substance alimentaire ou dietetique ayant une structure alveolaire, procede de preparation de ladite substance | |
| WO2000035437A3 (en) | Improving mental performance by increasing brain insulin sensitivity | |
| ES2111561T3 (es) | Derivados de benzopirano antihipertensivos. | |
| FR2387653A1 (fr) | Solutions aqueuses steriles contenant une substance a base d'hydrates de carbone et destinees a etre administrees par voie parenterale ainsi que leur procede de preparation | |
| Morse et al. | Multiple-dose pharmacokinetics of oral zidovudine in hemophilia patients with human immunodeficiency virus infection | |
| IE883600L (en) | d1-5-£(2-BENZYL-3,4-DIHYDRO-2H-BENZOPYRAN-6-YL)METHYL| THIAZOLIDINE-2,4-DIONE AS AN ANTI-ATHEROSCLEROSIS AGENT | |
| FR2361109A1 (fr) | Medicaments anthelminthiques | |
| IT1237435B (it) | Farmaco attivo nel ripristino della plasticita' neuronale. | |
| KR950002776A (ko) | 혈당 강하조성물 | |
| HUT45980A (en) | Process for production of derivatives of 5-hidroxi-pgf-below-alpha-1,5-lactone |